The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 18th May 2023 15:03

Friday 19 May 
IQE PLCFull Year Results
Knights Group Holdings PLCTrading Statement
Smiths Group PLCQ3 Results
Titon Holdings PLCHalf Year Results
Tharisa PLCHalf Year Results
Monday 22 May 
Big Yellow Group PLCFull Year Results
Chrysalis Investments LtdTrading Statement
Henderson European Focus Trust PLCHalf Year Results
Kainos Group PLCFull Year Results
Pershing Square Holdings LtdQ1 Results
Ryanair Holdings PLCFull Year Results
Schroder Oriental Income Fund LtdHalf Year Results
Wincanton PLCFull Year Results
Tuesday 23 May 
Assura PLCFull Year Results
Avon Protection PLCHalf Year Results
Benchmark Holdings PLCHalf Year Results
Bytes Technology Group PLCFull Year Results
Caledonian Trust PLCFull Year Results
Calnex Solutions PLCFull Year Results
Cranswick PLCFull Year Results
Engage XR Holdings PLCFull Year Results
FD Technologies PLCFull Year Results
Forterra PLCFull Year Results
Harworth Group PLCTrading Statement
Helical PLCFull Year Results
Hilton Food Group PLCTrading Statement
Ixico PLCHalf Year Results
JPMorgan China Growth & Income PLCHalf Year Results
Pebble Group PLCFull Year Results
Princess Private Equity Holding LtdQ1 Results
Residential Secure Income PLCHalf Year Results
RS Group PLCFull Year Results
Schroder AsiaPacific Fund PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
SSP Group PLCHalf Year Results
Topps Tiles PLCHalf Year Results
Trellus Health PLCFull Year Results
Victorian Plumbing Group PLCHalf Year Results
Watkin Jones PLCHalf Year Results
Wednesday 24 May 
Aviva PLCTrading Statement
Bakkavor Group PLCTrading Statement
Bodycote PLCTrading Statement
C&C Group PLCFull Year Results
Close Brothers Group PLCTrading Statement
Ediston Property Investment Co PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Esken LtdFull Year Results
Great Portland Estates PLCFull Year Results
Gym Group PLCTrading Statement
HICL Infrastructure PLCFull Year Results
Intertek Group PLCTrading Statement
Kier Group PLCTrading Statement
Kingfisher PLCQ1 Results
LondonMetric Property PLCFull Year Results
Majedie Investments PLCHalf Year Results
Marks & Spencer Group PLCFull Year Results
Mediclinic International PLCFull Year Results
Mortgage Advice Bureau Holdings PLCTrading Statement
N Brown Group PLCFull Year Results
Petershill Partners PLCTrading Statement
Purplebricks Group PLCTrading Statement
Regional REIT LtdTrading Statement
Severn Trent PLCFull Year Results
Sondrel Holdings PLCFull Year Results
SSE PLCFull Year Results
Tullow Oil PLCTrading Statement
Wynnstay Properties PLCFull Year Results
Zotefoams PLCTrading Statement
Thursday 25 May 
AJ Bell PLCHalf Year Results
Blackrock Frontiers Investment Trust PLCHalf Year Results
Caledonia Investments PLCFull Year Results
CT Private Equity Trust PLCQ1 Results
DWF Group PLCTrading Statement
Edinburgh Investment Trust PLCFull Year Results
Fevertree Drinks PLCTrading Statement
Headlam Group PLCTrading Statement
Henry Boot PLCTrading Statement
Hill & Smith PLCTrading Statement
Inspecs Group PLCTrading Statement
Intermediate Capital Group PLCFull Year Results
Jadestone Energy PLCFull Year Results
Johnson Mattey PLCFull Year Results
Pets At Home Group PLCFull Year Results
Pharos Energy PLCTrading Statement
Picton Property Income LtdFull Year Results
Qinetiq Group PLCFull Year Results
ReNeuron Group PLCFull Year Results
Renewi PLCFull Year Results
S&U PLCTrading Statement
Sabre Insurance Group PLCQ1 Results
Shires Income PLCFull Year Results
Tate & Lyle PLCFull Year Results
Triad Group PLCFull Year Results
United Utilities Group PLCFull Year Results
Vanquis Banking Group PLCTrading Statement
Workspace Group PLCFull Year Results
Young & Co's Brewery PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
12 Aug 2020 13:35

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

Read more
31 Jul 2020 16:22

ReNeuron gets patent allowance in the US

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.

Read more
31 Jul 2020 11:28

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

Read more
29 Jun 2020 20:39

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

Read more
25 Jun 2020 14:55

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

Read more
25 Jun 2020 11:22

ReNeuron Group inks research evaluation deal with US firm

(Sharecast News) - Cell-based therapeutics company ReNeuron Group announced on Thursday that it has signed a new research evaluation agreement with a major United States biotechnology company, in connection with the use of its proprietary exosomes for the delivery of novel gene silencing therapeutics.

Read more
17 Jun 2020 15:58

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

Read more
3 Apr 2020 11:41

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

Read more
24 Feb 2020 12:24

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Read more
17 Feb 2020 10:29

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more
6 Dec 2019 10:42

ReNeuron cuts losses after Fosun licence payment

(Sharecast News) - ReNeuron Group on Friday reported a narrower interim loss after receiving payment from a Chinese licensee, while it also made progress in its clinical and research programmes.

Read more
6 Dec 2019 09:32

ReNeuron Reports "Strong Progress" Across Various Programmes

ReNeuron Reports "Strong Progress" Across Various Programmes

Read more
29 Nov 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Oct 2019 15:50

ReNeuron presents new data on CTX stem cell platform

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Wednesday that new data relating to its CTX stem cell platform was being presented at the 27th Annual Congress of the European Society of Gene and Cell Therapy in Barcelona.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.